These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19282174)

  • 1. Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.
    Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2329-32. PubMed ID: 19282174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
    Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5893-7. PubMed ID: 19740658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.
    Paudel S; Cao Y; Guo S; An B; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Oct; 23(19):6418-26. PubMed ID: 26337019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.
    Fish PV; Andrews MD; Jonathan Fray M; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2009 May; 19(10):2829-34. PubMed ID: 19359175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3.
    Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Atkinson ST; Hertel LW; Nelson DL; Wainscott DB; Ahmad LJ; Shaw J; Threlkeld PG; Wong DT
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3939-42. PubMed ID: 14592479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2.
    Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Koch DJ; Atkinson ST; Hertel LW; Nelson DL; Wainscott DB; Ahmad LJ; Shaw J; Threlkeld PG; Wong DT
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2393-7. PubMed ID: 12824042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
    Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
    J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.
    Middleton DS; Andrews M; Glossop P; Gymer G; Hepworth D; Jessiman A; Johnson PS; Mackenny M; Pitcher MJ; Rooker T; Stobie A; Tang K; Morgan P
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4018-21. PubMed ID: 18571404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.
    Wu YJ; He H; Bertekap R; Westphal R; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
    Bioorg Med Chem; 2013 Apr; 21(8):2217-2228. PubMed ID: 23477943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs.
    Mehr-un-Nisa ; Munawar MA; Lee YS; Rankin D; Munir J; Lai J; Khan MA; Hruby VJ
    Bioorg Med Chem; 2015 Mar; 23(6):1251-9. PubMed ID: 25703306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and 5HT modulating activity of stereoisomers of 3-phenoxymethyl-4-phenylpiperidines.
    Engelstoft M; Hansen JB
    Acta Chem Scand (Cph); 1996 Feb; 50(2):164-9. PubMed ID: 8819850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient procedure for the synthesis of nonsymmetrical bivalent selective serotonin reuptake inhibitors using polymer-supported reagents.
    Tamiz AP; Conti P; Zhang M; Johnson KM; Kozikowski AP
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2741-3. PubMed ID: 11133081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
    Wen H; Qin W; Yang G; Guo Y
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT(1A) and 5-HT re-uptake ligands.
    van Niel MB; Beer MS; Castro JL; Cheng SK; Evans DC; Heald A; Hitzel L; Hunt P; Mortishire-Smith R; O'Connor D; Watt AP; MacLeod AM
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3243-8. PubMed ID: 10576696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors.
    Boot J; Cases M; Clark BP; Findlay J; Gallagher PT; Hayhurst L; Man T; Montalbetti C; Rathmell RE; Rudyk H; Walter MW; Whatton M; Wood V
    Bioorg Med Chem Lett; 2005 Feb; 15(3):699-703. PubMed ID: 15664840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?
    Schuster C; Fernbach N; Rix U; Superti-Furga G; Holy M; Freissmuth M; Sitte HH; Sexl V
    Biochem Pharmacol; 2007 Nov; 74(9):1424-35. PubMed ID: 17709099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action.
    Ghoneim OM; Ibrahim DA; El-Deeb IM; Lee SH; Booth RG
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6714-23. PubMed ID: 21982496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and 5-HT reuptake inhibition activity of biarylbenzamidine derivatives].
    Qin F; Wang NS; Yang J; Zhang JJ; Wang YF; Yang GZ
    Yao Xue Xue Bao; 2008 Jun; 43(6):619-25. PubMed ID: 18822965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT
    Yoshinaga H; Nishida T; Sasaki I; Kato T; Oki H; Yabuuchi K; Toyoda T
    Bioorg Med Chem; 2018 May; 26(8):1614-1627. PubMed ID: 29456112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.